Pfizer Inc - aktuální graf a vývoj ceny
Better Buy: Pfizer Inc. vs. Eli Lilly and Company
Better Buy: Pfizer Inc. vs. Eli Lilly and Company Motley Fool - Jul 1, 2017 Pfizer (NYSE:PFE) might be more than twice as big as fellow drugmaker Eli Lilly and Company (NYSE:LLY), but Lilly has been the better investment choice for quite a while.01. 07. 2017
Pfizer: Is It Really That Bad?
Pfizer: Is It Really That Bad? Seeking Alpha - Jul 6, 2017 And indeed this can cause problems for Pfizer, but this company is more than capable of offsetting these difficulties.06. 07. 2017
Pfizer: We Still Like You But…
Pfizer: We Still Like You But… Barron's - Jul 20, 2017 It's not that Credit Suisse analyst Vamil Divan and team don't like Pfizer. In fact, they call themselves "long-time supporters" of the company, and see "opportunities for upside over the long term." So why are they downgrading Pfizer? I'll let them ... Analyst Prescribes Neutral Rating For Pfizer Shares - Benzinga Pfizer Downgraded on Patent Expiration for Viagra: Credit Suisse - Investopedia20. 07. 2017